Page last updated: 2024-10-24

celecoxib and Cephalgia Syndromes

celecoxib has been researched along with Cephalgia Syndromes in 2 studies

Research Excerpts

ExcerptRelevanceReference
"Indomethacin-responsive headaches encompass a group of disorders which include a subset of the trigeminal autonomic cephalalgias and other paroxysmal, often precipitated primary headaches."8.12Etoricoxib and celecoxib sensitive indomethacin-responsive headache disorders. ( Bahra, A; Farag, M, 2022)
"Indomethacin-responsive headaches encompass a group of disorders which include a subset of the trigeminal autonomic cephalalgias and other paroxysmal, often precipitated primary headaches."4.12Etoricoxib and celecoxib sensitive indomethacin-responsive headache disorders. ( Bahra, A; Farag, M, 2022)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Farag, M1
Bahra, A1
Rossi, P1
Tassorelli, C1
Allena, M1
Ferrante, E1
Lisotto, C1
Nappi, G1

Reviews

1 review available for celecoxib and Cephalgia Syndromes

ArticleYear
Focus on therapy: hemicrania continua and new daily persistent headache.
    The journal of headache and pain, 2010, Volume: 11, Issue:3

    Topics: Amines; Analgesics; Celecoxib; Clinical Trials as Topic; Cyclohexanecarboxylic Acids; Fructose; Gaba

2010

Other Studies

1 other study available for celecoxib and Cephalgia Syndromes

ArticleYear
Etoricoxib and celecoxib sensitive indomethacin-responsive headache disorders.
    Headache, 2022, Volume: 62, Issue:3

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Etoricoxib; Headache; Headache Disorders; Humans

2022